Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investment rights law firm, announces that it has filed a class action lawsuit on behalf of buyers of AstraZeneca PLC (NASDAQ: LON: ) securities between March 23, 2022 and December 17, 2024, both days inclusive. “Team Time”). The class action is now done. If you wish to act as the lead plaintiff, you must remove the Court before March 21, 2025 in the securities class action previously filed by the Firm.
NOW: If you have purchased AstraZeneca (NASDAQ:) Securities during the Group period you may be entitled to receive compensation without payment of out-of-pocket costs or expenses through a contingency fee arrangement.
WHAT YOU NEED TO DO: To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action. A class action lawsuit has been filed. If you wish to act as the lead plaintiff, you must remove the Court before March 21, 2025. The lead plaintiff is the party representing the other members of the class to conduct the case.
WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Oftentimes, the companies that issue the notices don’t have the experience, the resources, or any meaningful peer recognition. Be smart when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder litigation. The Rosen Law Firm has reached the largest settlement of a class action against a Chinese Company at that time. Rosen Law Firm is ranked No. 1 by ISS Securities Group Action (WA:) Securities ranking services in 2017. The firm has been ranked 4th every year since 2013 and has earned hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Most of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
FACTS OF THE CASE: According to the lawsuit, the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca committed insurance fraud in China; (2) as a result, AstraZeneca faced severe legal backlash in China, which ultimately resulted in AstraZeneca’s China President being arrested by Chinese law enforcement authorities; (3) as a result, AstraZeneca mitigated its legal risks; (4) the foregoing, once disclosed, could harm AstraZeneca’s business activities in China; and (5) as a result, the defendants’ representations about its business, operations, and prospects, were false and misleading and/or had no reasonable basis at all relevant times . When the real facts entered the market, the lawsuit alleges that investors were harmed.
To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action.
No Group Guaranteed. Until the group is confirmed, you are not represented by a counselor unless you have reserved one. You can choose a consultant of your choice. You can remain a member of the missing group and do nothing at this point. The investor’s ability to contribute to future recovery does not depend on serving as the lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): /www .facebook.com/rosenlawfirm.
Advertising Attorney. Preliminary results do not guarantee a similar outcome.
——————————
Contact information:
To view the source version of this release, please visit https://www.newsfilecorp.com/release/235453
